The antithrombotic effects after
intravenous administration of a
low molecular weight heparin (LHN-1) and conventional
heparin were compared in a rabbit model of experimental
thrombosis, where
thrombus formation was induced by a combination of endothelial damage and stasis. Both compounds were able to prevent
thrombosis completely. However,
LHN-1 was significantly less potent than conventional
heparin, the ratio between doses with the same antithrombotic effect being 2.4:1 on a weight basis. Bleeding times after administration of
LHN-1 and conventional
heparin were determined by tail transsection in anaesthetized rats and by template
bleeding in the ear of conscious pigs. Given intravenously at a dose ratio of 2.4:1 (w/w),
LHN-1 affected APTT less than conventional
heparin, whereas the effects on haemostasis were not significantly different. In conclusion, it was found that after
intravenous administration LHN-1 prevented experimental
thrombosis as effectively as conventional
heparin. However, the correlation between antithrombotic and haemorrhagic effects of
LHN-1 was the same as that of conventional
heparin. The corresponding relation in man remains to be determined.